Association between walking 5000 step/day and fall incidence over six months in urban community-dwelling older people

por Aranyavalai, T., Jalayondeja, C., Jalayondeja, W., Pichaiyongwongdee, S., Kaewkungwal, J., Laskin, J. J.
Publicado 2020

P14-05. Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand

por Pitisuttithum, P, Rerks-Ngarm, S, Kaewkungwal, J, Nitayaphan, S, Khamboonruang, C, Kunasol, P, Suntharasamai, P, Benenson, MW, Kim, JH
Publicado 2009

P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand

por Kaewkungwal, J, Pitisuttithum, P, Nitayapan, S, Khamboonruang, C, Khamboonruang, C, Thongchareon, P, Kunasol, P, Benenson, M, Kim, J
Publicado 2009

Spatio-temporal patterns of leptospirosis in Thailand: is flooding a risk factor?

por SUWANPAKDEE, S., KAEWKUNGWAL, J., WHITE, L. J., ASENSIO, N., RATANAKORN, P., SINGHASIVANON, P., DAY, N. P. J., PAN-NGUM, W.
Publicado 2015

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

por Kim, JH, Kamasuta, C, Trichavaroj, R, Kaewkungwal, J, Chantakulkij, S, Ratto-Kim, S, Eamsila, C, Sukwit, S, Nitayaphan, S, Pitsuttihum, P, Michael, NL, Chiu, J, Rerks-Ngarm, S, de Souza, MS, Paris, RM
Publicado 2009

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family

por Bonsignori, M, Pollara, J, Moody, MA, Kepler, TB, Chen, X, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, JH, Michael, NL, Montefiori, DC, Liao, H, Ferrari, G, Haynes, BF
Publicado 2012

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes

por Pollara, J, Bonsignori, M, Moody, M, Alam, M, Liao, H, Hwang, K, Pickeral, J, Kappes, J, Ochsenbauer, C, Soderberg, K, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Montefiori, D, Robinson, JE, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, J, Michael, N, Tomaras, G, Haynes, BF, Ferrari, G
Publicado 2012

Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine

por Fourati, Slim, Ribeiro, Susan Pereira, Blasco Tavares Pereira Lopes, Filipa, Talla, Aarthi, Lefebvre, Francois, Cameron, Mark, Kaewkungwal, J., Pitisuttithum, P., Nitayaphan, S., Rerks-Ngarm, S., Kim, Jerome H., Thomas, Rasmi, Gilbert, Peter B., Tomaras, Georgia D., Koup, Richard A., Michael, Nelson L., McElrath, M. Juliana, Gottardo, Raphael, Sékaly, Rafick-Pierre
Publicado 2019

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2

por Liao, L, Bonsignori, M, Hwang, K, Moody, AM, Park, R, Crawford, S, Chen, H, Jeffries, TL, Cooper, M, Lu, X, De, R, Karasavvas, N, Rerks-Ngarm, S, Nitayaphan, S, Kaewkungwal, J, Tovanabutra, S, Pitisuttithum, P, Tartaglia, J, Sinangil, F, Kim, J, Michael, NL, Tomaras, GD, Yang, Z, Dai, K, Pancera, M, Nabel, GJ, Mascola, JR, Kwong, PD, Pinter, A, Zolla-Pazner, S, Alam, MS, Haynes, BF
Publicado 2012